• Long-Term Safety Study of Azacitidine for Patients with Blood Disorders Who Previously Participated in Azacitidine Clinical Trials

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland

  • Study on the Effects of Oral Semaglutide on Bone Health in Patients with Type 2 Diabetes and Low Bone Mass

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Study on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Germany Hungary Italy The Netherlands +4

  • Study on Human Normal Immunoglobulin to Prevent Early Infections in Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Estonia Norway

  • Study of Zanubrutinib and Tacrolimus for Patients with Primary Membranous Nephropathy

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Italy Poland Spain

  • Study Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia France Germany Hungary +3

  • Study on the Effectiveness of Mesenchymal Stromal Cells in Children with Steroid-Refractory Acute Graft-Versus-Host Disease

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    France Germany Italy Poland Spain

  • Study on the Safety and Tolerability of Lasmiditan for Treating Migraine in Children Aged 6 to 17

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium France Germany Italy The Netherlands Romania +1

  • Study on the Effectiveness and Safety of Ruxolitinib Cream for Adults with Chronic Hand Eczema

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Poland

  • Study of MK-7684A with Chemoradiotherapy Compared to Chemoradiotherapy with Durvalumab for Patients with Stage III Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Croatia Czechia France Germany Greece +5

powered by